SlideShare uma empresa Scribd logo
1 de 44
HUMAN ANTIBODIES
 FROM TRANSGENIC
     ANIMALS


                                  S. Kumarakurubaran,




     CENTRE FOR PLANT MOLECULAR
              BIOLOGY
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     2
Introduction

Monoclonal antibodies has been extensively
  used from its discovery
These monoclonal antibodies are used in the
  field of medicine for therapeutic applications
The research in the field of immunology has
  flourished to produce human antibodies from
  transgenic animals


                  HUMAN ANTIBODIES FROM
                   TRANSGENIC ANIMALS              3
CELL CULTURE



 Itis defined as the culturing up
  of individual cells or by
  disaggregated cell mass, either
  totipotent or pleuripotent, in a
  suitable culture medium

             HUMAN ANTIBODIES FROM
              TRANSGENIC ANIMALS     4
THREE ROUTES FOR DESTINATION


 ANIMALCELL CULTURE
 TRANSGENIC ANIMALS
 IMMUNOLOGY OF MAbs



           HUMAN ANTIBODIES FROM
            TRANSGENIC ANIMALS     5
HISTORY
 Alexis  carrel(1912)-chick embryo tissue
  extract increases cell proliferation in vitro
 Fibrin clot plasma used as solid support

 Ross harrison(1907)cultured embryonic
  nerve cell of frog
 Using Hanging drop method

 Carcinoma cell line HE LA, myeloma cells
  identified
                 HUMAN ANTIBODIES FROM TRANSGENIC   6
                             ANIMALS
Contd….


 1966 Alec Issacs discovered filtrates have
  secretions called interferon
 Chinese hamster ovary cells were cultured

 High density culturing methods were found

 Stem cell technology was discovered

 1996 Dolly was produce by egg enucleation




               HUMAN ANTIBODIES FROM TRANSGENIC   7
                           ANIMALS
CHARACTERISTICS OF ANIMAL
CELL

 Grow  only to a limited number of
  generations
 Neurons cannot divide to grow

 Skin cells grow only for a few generation

 Process of contact inhibition



               HUMAN ANTIBODIES FROM TRANSGENIC   8
                           ANIMALS
SUBSTRATES
Plastics-polystyrenes,                    PTTES, TPS,
 PVC
Glass, methyl celluloses

Metallic surface

Adhesives-d lysine, gelatin,

Feeder layer for glial cells
            HUMAN ANTIBODIES FROM TRANSGENIC         9
                        ANIMALS
MEDIA
pH ,osmotic pressure, gas phases
NATURAL MEDIA
Plasma clots
Biological fluids
SYNTHETIC MEDIA
Serum containing
Serum free

            HUMAN ANTIBODIES FROM TRANSGENIC   10
                        ANIMALS
COMPOSITION

 Serum
 Proteins
 Carbohydrates
 Co factors
 Examples-MEM,CMRL media

               HUMAN ANTIBODIES FROM
                TRANSGENIC ANIMALS     11
CELL LINES

 Finite   cell lines-Epidermal
  cells,
 Infinite cell lines- Cancerous
  cells

                HUMAN ANTIBODIES FROM
                 TRANSGENIC ANIMALS     12
MODEL ORGANISM
MICE
-short oestrous cycle, and gestation period
-relatively short generation time
-several litters per pregnancy
-Convenient in vitro fertilization
-successful in vitro embryo culture
-production and maintenance of ES lines
                HUMAN ANTIBODIES FROM
                 TRANSGENIC ANIMALS           13
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     14
Transgenic animals
 Method of introducing transgene


Transfection
 Transient-transgene gradually lost
   from daughter cells
 Stable-retained and expressed in all
   the cells derived from transfected
   cells
              HUMAN ANTIBODIES FROM      15
               TRANSGENIC ANIMALS
Transfection methods
 Calcium phosphate precipitation
 DEAE-dextran mediated transfection
 Lipofection
 Retroviral vector infection
 Microinjection
 Embryonic stem cell transfer

                              Mark.M.Davis (2004)
               HUMAN ANTIBODIES FROM
                TRANSGENIC ANIMALS                  16
HUMAN ANTIBODIES FROM   Gardener et al., 2003
 TRANSGENIC ANIMALS                             17
Gardener et al., 2003
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS                       18
VECTORS
 Simian virus 40
 Bovine papilloma virus with transforming
  region of pBR322
 Polyoma virus
 Vaccinia virus
 P element vectors
 Baculovirus vectors

                HUMAN ANTIBODIES FROM
                 TRANSGENIC ANIMALS          19
Gene construct
 Promoter/enhancer element
   RSV, SV40, β-casein
 Initiation codon, Gene of interest
 Reporter gene
 scorable marker β- galactosidase, lux
 selectable marker-thymidine kinase
 Termination signal, Poly A tail
               HUMAN ANTIBODIES FROM
                TRANSGENIC ANIMALS        20
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     21
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     22
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     23
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     24
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     25
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     26
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     27
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     28
Milstein and Kohler 1975




                  HUMAN ANTIBODIES FROM
                   TRANSGENIC ANIMALS     29
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS     30
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS                          31
                        Nil Lonberg (2005)
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS
                        Nil Lonberg (2005   32
Nil Lonberg (2005)
HUMAN ANTIBODIES FROM
 TRANSGENIC ANIMALS                          33
MONOCLONAL ANTIBODY
Derived from single cell line have identical
 structure binds same epitope,
Specific antigen is repeatedly injected and
 and spleen cells are extracted to obtain
 MAbs



                 HUMAN ANTIBODIES FROM
                  TRANSGENIC ANIMALS           34
Applications
Highly sensitive (magic bullets) epitopes
  helps in in vitro
Immuno diagnostics (detection and
  quantification)
Used in treatment of cancer, delivers drugs
  specifically to target tumor cells.


                HUMAN ANTIBODIES FROM
                 TRANSGENIC ANIMALS           35
Negative effects
 Antibodies recognized as murine
  antibodies and mounts immune response
  and eliminates from the body.
 Causes serious allergenicity to the level
  of lethality.
 Repeated use of mouse antibodies
  induces host to produce antibodies that
  neutralizes mouse antibody called HAMA
                HUMAN ANTIBODIES FROM
                 TRANSGENIC ANIMALS       36
Chimerised & human antibodies
 Variable region is obtained from non
  human rat antibody
 Constant region is obtained from human
  sequence
 Chimerics exhibit lower immunogenicity to
  the host
 Still the chimeric sequence requires
  changes this is done by r-DNA by
  engineering specific amino acid sequence
                HUMAN ANTIBODIES FROM
                 TRANSGENIC ANIMALS       37
Contd..
 Humanised to make more compatible
 Utilizes recombinant DNA technology
 Epitopes are substituted with human gene
  sequences
 Constant regions are derived from human




               HUMAN ANTIBODIES FROM
                TRANSGENIC ANIMALS       38
Human monoclonal antibodies
  from SCID mouse by injecting human B
  and T cells and grafting mouse by
  transplanting spleens and lymph nodes
 The transplanted mouse is immunized
  with target antigens to produce human
  antibodies
 Phage derived combinatorial antibody
  library, phage display technique-mimics in
  vitro affinity maturation
                HUMAN ANTIBODIES FROM
                 TRANSGENIC ANIMALS        39
Hybridoma technology
   First discovered by Milstein and Kohler 1975
   Specific antigen is given repeatedly to the host
   The spleen producing B cells are isolated
   B cells are fused with myeloma cells that are
    immortal and this is called hybridoma cells
   This produces specific antibody indefinitely
    precisely can be isolated easily


                     HUMAN ANTIBODIES FROM
                      TRANSGENIC ANIMALS               40
HUMAN ANTIBODIES FROM   William Fodor
                                 41
 TRANSGENIC ANIMALS
                             2004
CHARACTERISTICS
POLYCLONAL ANTIBODY               MONOCLONAL ANTIBODY
   Contains many                    Contains single specific
    antigenic determinants            determinant
   Produces various                 Single class of antibody
    classes                           is produced
   Reproducibility and              Highly reproducible
    standardization is
    difficult

                      HUMAN ANTIBODIES FROM
                       TRANSGENIC ANIMALS                  42
CONCLUSION




  HUMAN ANTIBODIES FROM
   TRANSGENIC ANIMALS     43
HUMAN ANTIBODIES FROM   44
 TRANSGENIC ANIMALS

Mais conteúdo relacionado

Mais procurados

2 whole genome sequencing and analysis
2 whole genome sequencing and analysis2 whole genome sequencing and analysis
2 whole genome sequencing and analysissaberhussain9
 
Adenoviral vector
Adenoviral vectorAdenoviral vector
Adenoviral vectormanojjeya
 
Cell culture based vaccine
Cell culture based vaccineCell culture based vaccine
Cell culture based vaccineKAUSHAL SAHU
 
Ethical issues related to animal biotechnology
Ethical issues related to animal biotechnologyEthical issues related to animal biotechnology
Ethical issues related to animal biotechnologyKAUSHAL SAHU
 
Dna vaccine final ppt
Dna vaccine final pptDna vaccine final ppt
Dna vaccine final pptTaye Desta
 
Antibody engineering by R.S.Priyengha
Antibody engineering by R.S.PriyenghaAntibody engineering by R.S.Priyengha
Antibody engineering by R.S.PriyenghaPriyengha R.S
 
Hybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyHybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyRajpal Choudhary
 
Primary culture and cell line
Primary culture and cell linePrimary culture and cell line
Primary culture and cell lineKAUSHAL SAHU
 
cell culture based vaccine
cell culture based vaccinecell culture based vaccine
cell culture based vaccinesajal shrivastav
 
Antibody phage display technology
Antibody phage display technologyAntibody phage display technology
Antibody phage display technology1431122
 
Monoclonal Antibody and Hybridoma technology
Monoclonal Antibody and Hybridoma technologyMonoclonal Antibody and Hybridoma technology
Monoclonal Antibody and Hybridoma technologyD.R. Chandravanshi
 
Characterization of Cell Line
Characterization of Cell LineCharacterization of Cell Line
Characterization of Cell LineVarij Nayan
 
Monoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringMonoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringARUNDHATI MEHTA
 

Mais procurados (20)

2 whole genome sequencing and analysis
2 whole genome sequencing and analysis2 whole genome sequencing and analysis
2 whole genome sequencing and analysis
 
Adenoviral vector
Adenoviral vectorAdenoviral vector
Adenoviral vector
 
Crisper Cas system
Crisper Cas systemCrisper Cas system
Crisper Cas system
 
Cell culture based vaccine
Cell culture based vaccineCell culture based vaccine
Cell culture based vaccine
 
Transfection method
Transfection methodTransfection method
Transfection method
 
Nanobodies
NanobodiesNanobodies
Nanobodies
 
Ethical issues related to animal biotechnology
Ethical issues related to animal biotechnologyEthical issues related to animal biotechnology
Ethical issues related to animal biotechnology
 
Dna vaccine final ppt
Dna vaccine final pptDna vaccine final ppt
Dna vaccine final ppt
 
Antibody engineering by R.S.Priyengha
Antibody engineering by R.S.PriyenghaAntibody engineering by R.S.Priyengha
Antibody engineering by R.S.Priyengha
 
Hybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyHybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibody
 
Primary culture and cell line
Primary culture and cell linePrimary culture and cell line
Primary culture and cell line
 
cell culture based vaccine
cell culture based vaccinecell culture based vaccine
cell culture based vaccine
 
Whole genome sequencing
Whole genome sequencingWhole genome sequencing
Whole genome sequencing
 
Antibody phage display technology
Antibody phage display technologyAntibody phage display technology
Antibody phage display technology
 
Tumour immunology
Tumour immunologyTumour immunology
Tumour immunology
 
Phage therapy
Phage therapyPhage therapy
Phage therapy
 
Monoclonal Antibody and Hybridoma technology
Monoclonal Antibody and Hybridoma technologyMonoclonal Antibody and Hybridoma technology
Monoclonal Antibody and Hybridoma technology
 
Characterization of Cell Line
Characterization of Cell LineCharacterization of Cell Line
Characterization of Cell Line
 
PHAGEMID.pdf
PHAGEMID.pdfPHAGEMID.pdf
PHAGEMID.pdf
 
Monoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringMonoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody Engineering
 

Destaque

Human monoclonal antibody development
Human monoclonal antibody developmentHuman monoclonal antibody development
Human monoclonal antibody developmenthumanantibodies
 
Lecture 8 genetic engineering of animal cells
Lecture 8   genetic engineering of animal cellsLecture 8   genetic engineering of animal cells
Lecture 8 genetic engineering of animal cellsSarah Aira Santos
 
Therapeutic antibodies 4_humanization (2)
Therapeutic antibodies 4_humanization (2)Therapeutic antibodies 4_humanization (2)
Therapeutic antibodies 4_humanization (2)FREE EDUCATION FOR ALL
 
Clinical Research In Lupus by Dr. Meggan Mackay
Clinical Research In Lupus by Dr. Meggan MackayClinical Research In Lupus by Dr. Meggan Mackay
Clinical Research In Lupus by Dr. Meggan MackayLupusNY
 
Transfection – basics & optimization tips
Transfection – basics & optimization tipsTransfection – basics & optimization tips
Transfection – basics & optimization tipsajithnandanam
 
Transgenic animals
Transgenic animals Transgenic animals
Transgenic animals MSCW Mysore
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animalsdamarisb
 
Group four(cloning) 2
Group four(cloning) 2Group four(cloning) 2
Group four(cloning) 2Manish Halai
 
Rituximab chimeric anti cd20 monoclonal antibody
Rituximab  chimeric anti cd20 monoclonal antibodyRituximab  chimeric anti cd20 monoclonal antibody
Rituximab chimeric anti cd20 monoclonal antibodyRSUPN cipto mangunkusumo
 
USE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASES
USE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASESUSE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASES
USE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASESdrarsalankhandvm
 
Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13LupusNY
 
Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...
Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...
Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...LupusNY
 
Skin Care, Weight Control, and Feeling Good with Lupus
Skin Care, Weight Control, and Feeling Good with LupusSkin Care, Weight Control, and Feeling Good with Lupus
Skin Care, Weight Control, and Feeling Good with LupusLupusNY
 
Lupus: Why am I hurting?
Lupus: Why am I hurting?Lupus: Why am I hurting?
Lupus: Why am I hurting?LupusNY
 
Lupus foundation educational program 2013
Lupus foundation educational program 2013Lupus foundation educational program 2013
Lupus foundation educational program 2013LupusNY
 
Sle body meds.onome
Sle body meds.onomeSle body meds.onome
Sle body meds.onomeLupusNY
 

Destaque (20)

Human monoclonal antibody development
Human monoclonal antibody developmentHuman monoclonal antibody development
Human monoclonal antibody development
 
Lecture 8 genetic engineering of animal cells
Lecture 8   genetic engineering of animal cellsLecture 8   genetic engineering of animal cells
Lecture 8 genetic engineering of animal cells
 
Therapeutic antibodies 4_humanization (2)
Therapeutic antibodies 4_humanization (2)Therapeutic antibodies 4_humanization (2)
Therapeutic antibodies 4_humanization (2)
 
Humanized antibody
Humanized antibodyHumanized antibody
Humanized antibody
 
Clinical Research In Lupus by Dr. Meggan Mackay
Clinical Research In Lupus by Dr. Meggan MackayClinical Research In Lupus by Dr. Meggan Mackay
Clinical Research In Lupus by Dr. Meggan Mackay
 
Transfection – basics & optimization tips
Transfection – basics & optimization tipsTransfection – basics & optimization tips
Transfection – basics & optimization tips
 
Transgenic animals ppt
Transgenic animals pptTransgenic animals ppt
Transgenic animals ppt
 
Transfection
TransfectionTransfection
Transfection
 
Transgenic animals
Transgenic animals Transgenic animals
Transgenic animals
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animals
 
Group four(cloning) 2
Group four(cloning) 2Group four(cloning) 2
Group four(cloning) 2
 
Rituximab chimeric anti cd20 monoclonal antibody
Rituximab  chimeric anti cd20 monoclonal antibodyRituximab  chimeric anti cd20 monoclonal antibody
Rituximab chimeric anti cd20 monoclonal antibody
 
USE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASES
USE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASESUSE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASES
USE OF EMBRYO TRANSFER IN THE CONTROL OF ANIMAL DISEASES
 
Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13Dr. johnson slide presentation 12.13
Dr. johnson slide presentation 12.13
 
Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...
Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...
Dr. Dan Wallace Presents “New Therapies for Lupus and Clinical Trials” at Lup...
 
Skin Care, Weight Control, and Feeling Good with Lupus
Skin Care, Weight Control, and Feeling Good with LupusSkin Care, Weight Control, and Feeling Good with Lupus
Skin Care, Weight Control, and Feeling Good with Lupus
 
Lupus: Why am I hurting?
Lupus: Why am I hurting?Lupus: Why am I hurting?
Lupus: Why am I hurting?
 
Lupus foundation educational program 2013
Lupus foundation educational program 2013Lupus foundation educational program 2013
Lupus foundation educational program 2013
 
Sle body meds.onome
Sle body meds.onomeSle body meds.onome
Sle body meds.onome
 
Therapeutic antibodies 5_humanization
Therapeutic antibodies 5_humanizationTherapeutic antibodies 5_humanization
Therapeutic antibodies 5_humanization
 

Semelhante a Human antibodies from transgenic animals

Antibodies drug delivery system
Antibodies drug delivery systemAntibodies drug delivery system
Antibodies drug delivery systemJamia Hamdard
 
Biotechnological pharmaceuticals
Biotechnological pharmaceuticalsBiotechnological pharmaceuticals
Biotechnological pharmaceuticalsGaurav Kr
 
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptxHYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptxSwati Gaikwad
 
Antibodies (Theraputic Protein) 2013.pptx
Antibodies (Theraputic Protein) 2013.pptxAntibodies (Theraputic Protein) 2013.pptx
Antibodies (Theraputic Protein) 2013.pptxAshhadHalimi1
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technologyilo0lo0
 
Biotechnology CLIL module
Biotechnology CLIL moduleBiotechnology CLIL module
Biotechnology CLIL moduletoenbruno
 
MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )N Anusha
 
hybridomatechnology-biotech pharmacy.pptx
hybridomatechnology-biotech pharmacy.pptxhybridomatechnology-biotech pharmacy.pptx
hybridomatechnology-biotech pharmacy.pptxsurya singh
 
Monoclonal antibody production
Monoclonal antibody productionMonoclonal antibody production
Monoclonal antibody productionSrilaxmiMenon
 
Monoclonal antibodies in ecoli
Monoclonal antibodies in ecoliMonoclonal antibodies in ecoli
Monoclonal antibodies in ecoliKhadeejaBiotech
 
Viruses- Pharmaceutical Microbiology
Viruses-  Pharmaceutical MicrobiologyViruses-  Pharmaceutical Microbiology
Viruses- Pharmaceutical MicrobiologySanchit Dhankhar
 
hybridoma technology.pptx
hybridoma technology.pptxhybridoma technology.pptx
hybridoma technology.pptxTejaswiniAsawa
 

Semelhante a Human antibodies from transgenic animals (20)

Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
 
Antibodies drug delivery system
Antibodies drug delivery systemAntibodies drug delivery system
Antibodies drug delivery system
 
Biotechnological pharmaceuticals
Biotechnological pharmaceuticalsBiotechnological pharmaceuticals
Biotechnological pharmaceuticals
 
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptxHYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
HYBRIDOMA_TECHNOLOGY_and_ITS_APPLICATION.pptx
 
Antibodies (Theraputic Protein) 2013.pptx
Antibodies (Theraputic Protein) 2013.pptxAntibodies (Theraputic Protein) 2013.pptx
Antibodies (Theraputic Protein) 2013.pptx
 
Saurabh verma
Saurabh vermaSaurabh verma
Saurabh verma
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
monoclonalantibodies.ppt
monoclonalantibodies.pptmonoclonalantibodies.ppt
monoclonalantibodies.ppt
 
Biotechnology CLIL module
Biotechnology CLIL moduleBiotechnology CLIL module
Biotechnology CLIL module
 
MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
hybridomatechnology-biotech pharmacy.pptx
hybridomatechnology-biotech pharmacy.pptxhybridomatechnology-biotech pharmacy.pptx
hybridomatechnology-biotech pharmacy.pptx
 
Monoclonal antibody production
Monoclonal antibody productionMonoclonal antibody production
Monoclonal antibody production
 
Monoclonal antibodies in ecoli
Monoclonal antibodies in ecoliMonoclonal antibodies in ecoli
Monoclonal antibodies in ecoli
 
Viruses- Pharmaceutical Microbiology
Viruses-  Pharmaceutical MicrobiologyViruses-  Pharmaceutical Microbiology
Viruses- Pharmaceutical Microbiology
 
hybridoma technology.pptx
hybridoma technology.pptxhybridoma technology.pptx
hybridoma technology.pptx
 
mAb
mAbmAb
mAb
 
VIROLOGY - CULTIVATION AND DETECTION OF VIRUS
VIROLOGY - CULTIVATION AND DETECTION OF VIRUSVIROLOGY - CULTIVATION AND DETECTION OF VIRUS
VIROLOGY - CULTIVATION AND DETECTION OF VIRUS
 

Mais de Senthil Natesan

Centre of innovation, Agricultural College and Research Institute,Madurai
Centre of innovation, Agricultural College and Research Institute,MaduraiCentre of innovation, Agricultural College and Research Institute,Madurai
Centre of innovation, Agricultural College and Research Institute,MaduraiSenthil Natesan
 
wheat association mapping LTN
wheat association mapping LTNwheat association mapping LTN
wheat association mapping LTNSenthil Natesan
 
Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...
Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...
Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...Senthil Natesan
 
The need for nutrient efficient rice varieties Status and prospects
The need for nutrient efficient rice varieties Status and prospectsThe need for nutrient efficient rice varieties Status and prospects
The need for nutrient efficient rice varieties Status and prospectsSenthil Natesan
 
Deployment of rust resistance genes in wheat varieties
Deployment of rust resistance genes in wheat varietiesDeployment of rust resistance genes in wheat varieties
Deployment of rust resistance genes in wheat varietiesSenthil Natesan
 
Genomics Assisted Breeding for Resilient Rice: Progress and Prospects
Genomics Assisted Breeding for Resilient Rice: Progress and ProspectsGenomics Assisted Breeding for Resilient Rice: Progress and Prospects
Genomics Assisted Breeding for Resilient Rice: Progress and ProspectsSenthil Natesan
 
COCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIA
COCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIACOCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIA
COCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIASenthil Natesan
 
Germplasm conservation in Oil Palm
Germplasm conservation in  Oil PalmGermplasm conservation in  Oil Palm
Germplasm conservation in Oil PalmSenthil Natesan
 
Improvement of Medicinal Plants: Challenges and Innovative Approaches
Improvement of Medicinal Plants: Challenges and Innovative ApproachesImprovement of Medicinal Plants: Challenges and Innovative Approaches
Improvement of Medicinal Plants: Challenges and Innovative ApproachesSenthil Natesan
 
Role of induced mutations in legume improvement-Dr.Souframanien
Role of induced mutations in legume improvement-Dr.SouframanienRole of induced mutations in legume improvement-Dr.Souframanien
Role of induced mutations in legume improvement-Dr.SouframanienSenthil Natesan
 
Towards improvement of oil content in safflower (Carthamus tinctorius L.)
Towards improvement of oil content in safflower (Carthamus tinctorius L.)Towards improvement of oil content in safflower (Carthamus tinctorius L.)
Towards improvement of oil content in safflower (Carthamus tinctorius L.)Senthil Natesan
 
New paradigm in Seed industry
New paradigm in Seed industryNew paradigm in Seed industry
New paradigm in Seed industrySenthil Natesan
 
Genomics platform for agriculture-CAT lecture
Genomics platform for agriculture-CAT lectureGenomics platform for agriculture-CAT lecture
Genomics platform for agriculture-CAT lectureSenthil Natesan
 
Castor database ; Casterdp
Castor database ; Casterdp Castor database ; Casterdp
Castor database ; Casterdp Senthil Natesan
 
Engineering fatty acid biosynthesis
Engineering fatty acid biosynthesisEngineering fatty acid biosynthesis
Engineering fatty acid biosynthesisSenthil Natesan
 
Cellular signal transduction pathways under abiotic stress
Cellular signal transduction pathways under abiotic stressCellular signal transduction pathways under abiotic stress
Cellular signal transduction pathways under abiotic stressSenthil Natesan
 
Genotyping by Sequencing
Genotyping by SequencingGenotyping by Sequencing
Genotyping by SequencingSenthil Natesan
 

Mais de Senthil Natesan (20)

Centre of innovation, Agricultural College and Research Institute,Madurai
Centre of innovation, Agricultural College and Research Institute,MaduraiCentre of innovation, Agricultural College and Research Institute,Madurai
Centre of innovation, Agricultural College and Research Institute,Madurai
 
Indian agriculture
Indian agriculture Indian agriculture
Indian agriculture
 
wheat association mapping LTN
wheat association mapping LTNwheat association mapping LTN
wheat association mapping LTN
 
Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...
Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...
Paradigm shift in breeding for Sugarcane to Energycane – An exclusive biofuel...
 
The need for nutrient efficient rice varieties Status and prospects
The need for nutrient efficient rice varieties Status and prospectsThe need for nutrient efficient rice varieties Status and prospects
The need for nutrient efficient rice varieties Status and prospects
 
Deployment of rust resistance genes in wheat varieties
Deployment of rust resistance genes in wheat varietiesDeployment of rust resistance genes in wheat varieties
Deployment of rust resistance genes in wheat varieties
 
Caster pollination
Caster pollination Caster pollination
Caster pollination
 
Genomics Assisted Breeding for Resilient Rice: Progress and Prospects
Genomics Assisted Breeding for Resilient Rice: Progress and ProspectsGenomics Assisted Breeding for Resilient Rice: Progress and Prospects
Genomics Assisted Breeding for Resilient Rice: Progress and Prospects
 
COCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIA
COCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIACOCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIA
COCONUT GENETIC RESOURCES CONSERVATION & UTILIZATION IN INDIA
 
Germplasm conservation in Oil Palm
Germplasm conservation in  Oil PalmGermplasm conservation in  Oil Palm
Germplasm conservation in Oil Palm
 
Improvement of Medicinal Plants: Challenges and Innovative Approaches
Improvement of Medicinal Plants: Challenges and Innovative ApproachesImprovement of Medicinal Plants: Challenges and Innovative Approaches
Improvement of Medicinal Plants: Challenges and Innovative Approaches
 
Role of induced mutations in legume improvement-Dr.Souframanien
Role of induced mutations in legume improvement-Dr.SouframanienRole of induced mutations in legume improvement-Dr.Souframanien
Role of induced mutations in legume improvement-Dr.Souframanien
 
Towards improvement of oil content in safflower (Carthamus tinctorius L.)
Towards improvement of oil content in safflower (Carthamus tinctorius L.)Towards improvement of oil content in safflower (Carthamus tinctorius L.)
Towards improvement of oil content in safflower (Carthamus tinctorius L.)
 
New paradigm in Seed industry
New paradigm in Seed industryNew paradigm in Seed industry
New paradigm in Seed industry
 
Genomics platform for agriculture-CAT lecture
Genomics platform for agriculture-CAT lectureGenomics platform for agriculture-CAT lecture
Genomics platform for agriculture-CAT lecture
 
Castor database ; Casterdp
Castor database ; Casterdp Castor database ; Casterdp
Castor database ; Casterdp
 
Engineering fatty acid biosynthesis
Engineering fatty acid biosynthesisEngineering fatty acid biosynthesis
Engineering fatty acid biosynthesis
 
Edible vaccine
Edible vaccineEdible vaccine
Edible vaccine
 
Cellular signal transduction pathways under abiotic stress
Cellular signal transduction pathways under abiotic stressCellular signal transduction pathways under abiotic stress
Cellular signal transduction pathways under abiotic stress
 
Genotyping by Sequencing
Genotyping by SequencingGenotyping by Sequencing
Genotyping by Sequencing
 

Último

Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxleah joy valeriano
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 

Último (20)

Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptxMusic 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
Music 9 - 4th quarter - Vocal Music of the Romantic Period.pptx
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 

Human antibodies from transgenic animals

  • 1. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS S. Kumarakurubaran, CENTRE FOR PLANT MOLECULAR BIOLOGY
  • 2. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 2
  • 3. Introduction Monoclonal antibodies has been extensively used from its discovery These monoclonal antibodies are used in the field of medicine for therapeutic applications The research in the field of immunology has flourished to produce human antibodies from transgenic animals HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 3
  • 4. CELL CULTURE  Itis defined as the culturing up of individual cells or by disaggregated cell mass, either totipotent or pleuripotent, in a suitable culture medium HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 4
  • 5. THREE ROUTES FOR DESTINATION  ANIMALCELL CULTURE  TRANSGENIC ANIMALS  IMMUNOLOGY OF MAbs HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 5
  • 6. HISTORY  Alexis carrel(1912)-chick embryo tissue extract increases cell proliferation in vitro  Fibrin clot plasma used as solid support  Ross harrison(1907)cultured embryonic nerve cell of frog  Using Hanging drop method  Carcinoma cell line HE LA, myeloma cells identified HUMAN ANTIBODIES FROM TRANSGENIC 6 ANIMALS
  • 7. Contd….  1966 Alec Issacs discovered filtrates have secretions called interferon  Chinese hamster ovary cells were cultured  High density culturing methods were found  Stem cell technology was discovered  1996 Dolly was produce by egg enucleation HUMAN ANTIBODIES FROM TRANSGENIC 7 ANIMALS
  • 8. CHARACTERISTICS OF ANIMAL CELL  Grow only to a limited number of generations  Neurons cannot divide to grow  Skin cells grow only for a few generation  Process of contact inhibition HUMAN ANTIBODIES FROM TRANSGENIC 8 ANIMALS
  • 9. SUBSTRATES Plastics-polystyrenes, PTTES, TPS, PVC Glass, methyl celluloses Metallic surface Adhesives-d lysine, gelatin, Feeder layer for glial cells HUMAN ANTIBODIES FROM TRANSGENIC 9 ANIMALS
  • 10. MEDIA pH ,osmotic pressure, gas phases NATURAL MEDIA Plasma clots Biological fluids SYNTHETIC MEDIA Serum containing Serum free HUMAN ANTIBODIES FROM TRANSGENIC 10 ANIMALS
  • 11. COMPOSITION  Serum  Proteins  Carbohydrates  Co factors  Examples-MEM,CMRL media HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 11
  • 12. CELL LINES  Finite cell lines-Epidermal cells,  Infinite cell lines- Cancerous cells HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 12
  • 13. MODEL ORGANISM MICE -short oestrous cycle, and gestation period -relatively short generation time -several litters per pregnancy -Convenient in vitro fertilization -successful in vitro embryo culture -production and maintenance of ES lines HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 13
  • 14. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 14
  • 15. Transgenic animals  Method of introducing transgene Transfection  Transient-transgene gradually lost from daughter cells  Stable-retained and expressed in all the cells derived from transfected cells HUMAN ANTIBODIES FROM 15 TRANSGENIC ANIMALS
  • 16. Transfection methods  Calcium phosphate precipitation  DEAE-dextran mediated transfection  Lipofection  Retroviral vector infection  Microinjection  Embryonic stem cell transfer Mark.M.Davis (2004) HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 16
  • 17. HUMAN ANTIBODIES FROM Gardener et al., 2003 TRANSGENIC ANIMALS 17
  • 18. Gardener et al., 2003 HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 18
  • 19. VECTORS  Simian virus 40  Bovine papilloma virus with transforming region of pBR322  Polyoma virus  Vaccinia virus  P element vectors  Baculovirus vectors HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 19
  • 20. Gene construct  Promoter/enhancer element RSV, SV40, β-casein  Initiation codon, Gene of interest  Reporter gene  scorable marker β- galactosidase, lux  selectable marker-thymidine kinase  Termination signal, Poly A tail HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 20
  • 21. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 21
  • 22. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 22
  • 23. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 23
  • 24. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 24
  • 25. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 25
  • 26. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 26
  • 27. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 27
  • 28. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 28
  • 29. Milstein and Kohler 1975 HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 29
  • 30. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 30
  • 31. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 31 Nil Lonberg (2005)
  • 32. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS Nil Lonberg (2005 32
  • 33. Nil Lonberg (2005) HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 33
  • 34. MONOCLONAL ANTIBODY Derived from single cell line have identical structure binds same epitope, Specific antigen is repeatedly injected and and spleen cells are extracted to obtain MAbs HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 34
  • 35. Applications Highly sensitive (magic bullets) epitopes helps in in vitro Immuno diagnostics (detection and quantification) Used in treatment of cancer, delivers drugs specifically to target tumor cells. HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 35
  • 36. Negative effects  Antibodies recognized as murine antibodies and mounts immune response and eliminates from the body.  Causes serious allergenicity to the level of lethality.  Repeated use of mouse antibodies induces host to produce antibodies that neutralizes mouse antibody called HAMA HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 36
  • 37. Chimerised & human antibodies  Variable region is obtained from non human rat antibody  Constant region is obtained from human sequence  Chimerics exhibit lower immunogenicity to the host  Still the chimeric sequence requires changes this is done by r-DNA by engineering specific amino acid sequence HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 37
  • 38. Contd..  Humanised to make more compatible  Utilizes recombinant DNA technology  Epitopes are substituted with human gene sequences  Constant regions are derived from human HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 38
  • 39. Human monoclonal antibodies  from SCID mouse by injecting human B and T cells and grafting mouse by transplanting spleens and lymph nodes  The transplanted mouse is immunized with target antigens to produce human antibodies  Phage derived combinatorial antibody library, phage display technique-mimics in vitro affinity maturation HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 39
  • 40. Hybridoma technology  First discovered by Milstein and Kohler 1975  Specific antigen is given repeatedly to the host  The spleen producing B cells are isolated  B cells are fused with myeloma cells that are immortal and this is called hybridoma cells  This produces specific antibody indefinitely precisely can be isolated easily HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 40
  • 41. HUMAN ANTIBODIES FROM William Fodor 41 TRANSGENIC ANIMALS 2004
  • 42. CHARACTERISTICS POLYCLONAL ANTIBODY MONOCLONAL ANTIBODY  Contains many  Contains single specific antigenic determinants determinant  Produces various  Single class of antibody classes is produced  Reproducibility and  Highly reproducible standardization is difficult HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 42
  • 43. CONCLUSION HUMAN ANTIBODIES FROM TRANSGENIC ANIMALS 43
  • 44. HUMAN ANTIBODIES FROM 44 TRANSGENIC ANIMALS